Key facts
- It has raised $5.9M across 3 recorded rounds; the latest was Seed Round ($1.1M) in Oct 2023.
- Deinde Medical has filed 5 Form Ds with the SEC since 2019, most recently Nov 2025 ($185K sold to 3 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 3 rounds
- ·Watchlist + deal alerts for Deinde Medical
Funding rounds
3 roundsAbout Deinde Medical
Developer of neuro-interventional tools intended for invasive brain surgery. The company offers experienced clinical advisors for quick evaluation both in tabletop models and in pre-clinical settings, enabling healthcare institutions to reduce morbidity as well as patient recovery time.
- Sector
- Healthcare
- HQ
- Miramar, FL, United States
- Founded
- 2019
- Employees
- 3
- Website
- deindemedical.com/
- Ownership
- Privately Held (backing)
Deinde Medical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Deinde Medical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Deinde Medical in its N-PORT filings yet. We sweep new filings monthly.